Our Mission
Our mission is to help patients Live Every Day to the fullest. Existing treatments only partially alleviate symptoms and often come with unwanted side effects. We strive to develop safe, effective, and non-addictive medications for pain and neurological diseases.
Leveraging Multimodality Towards Safe And Effective Treatments
BRC’s therapeutics integrate the benefits of botanically derived products with the rigor of regulatory approval. All our drug candidates are proprietary and subject to FDA approval. Our goal is to provide patients and physicians with GMP manufactured, non-addictive solutions at dosages that take the guesswork out of currently available botanically derived treatments.
“I started BRC after seeing my friend and fellow veteran suffer from conditions with no approved treatments. When inquiring about cannabinoids, the medical community didn’t have the answers we were looking for. There was simply no effective treatment out there that had been rigorously tested for safety and approved by regulatory authorities. We want to change that.”
– George Hodgin Founder & CEO
Key milestones
BRC has met significant milestones since inception and obtained a full set of DEA licenses within only a few years. Due to the documented safety profile of certain botanically derived cannabinoids, we were able to accelerate the entry of our candidates into investigator-initiated clinical trials.
Our Business Model: Maximizing Innovation
• Unique ratios
• Intellectual Property
• Investigator-initiated trials
• Industry partnerships
• Co-Development
• Strategic alliances
